Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor
暂无分享,去创建一个
Seunggyun Ha | Dong-Wan Kim | D. Heo | B. Keam | T. Kim | Se-Hoon Lee | J. Paeng | Sehhoon Park